Inceptor Bio Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
23
- Latest Deal Type
-
Series A2
- Latest Deal Amount
-
$21M
- Investors
-
2
Inceptor Bio General Information
Description
Operator of a biotechnology platform intended for advancing research and developing therapies to cure cancer. The company's platform identifies, incubates, and accelerates novel cell and genetic therapy technologies that maintain stemness and effector function within the tumor microenvironment to enhance immune cell performance and resistance to exhaustion, providing patients with improved cancer treatment.
Contact Information
Website
www.inceptor.bioCorporate Office
- 2450 Perimeter Park Drive
- Suite 200
- Morrisville, NC 27560
- United States
Corporate Office
- 2450 Perimeter Park Drive
- Suite 200
- Morrisville, NC 27560
- United States
Inceptor Bio Timeline
Inceptor Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A2) | 26-Feb-2025 | $21M | Completed | Pre-Clinical Trials | ||
| 3. Debt - General | 22-Jul-2024 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC (Series A) | 04-Mar-2022 | $37.7M | $41M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 01-Jan-2020 | $3.25M | $3.25M | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Inceptor Bio Comparisons
Industry
Financing
Details
Inceptor Bio Competitors (3)
One of Inceptor Bio’s 3 competitors is Poseida Therapeutics, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Poseida Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Carisma Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| Allogene Therapeutics | Formerly VC-backed | South San Francisco, CA |
Inceptor Bio Patents
Inceptor Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026047626-A1 | Compositions and methods involving immune cells engineered for binding bispecific antibodies for use in cell therapy | Pending | 30-Aug-2024 | ||
| WO-2025046513-A1 | Methods of manufacturing myeloid-derived cells from hematopoietic stem cells and compositions and uses thereof | Inactive | 29-Aug-2023 | ||
| AU-2024290220-A1 | Compositions and methods for culturing t cells | Pending | 05-Jul-2023 | ||
| EP-4739769-A1 | Compositions and methods for culturing t cells | Pending | 05-Jul-2023 | ||
| WO-2025008798-A1 | Compositions and methods for culturing t cells | Inactive | 05-Jul-2023 | C12N5/0636 |
Inceptor Bio Signals
Inceptor Bio Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kineticos Life Sciences Management | Venture Capital | Minority | ||
| Next Coast Ventures | Venture Capital | Minority |
Inceptor Bio Acquisitions (1)
Inceptor Bio’s most recent deal was a Merger/Acquisition with Arranta Bio (Process Development and GMP Clinical Manufacturing Business in Gainesville, Florida). The deal was made on 15-Nov-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Arranta Bio (Process Development and GMP Clinical Manufacturing Business in Gainesville, Florida) | 15-Nov-2021 | Merger/Acquisition | Drug Discovery |
Inceptor Bio FAQs
-
When was Inceptor Bio founded?
Inceptor Bio was founded in 2020.
-
Where is Inceptor Bio headquartered?
Inceptor Bio is headquartered in Morrisville, NC.
-
What is the size of Inceptor Bio?
Inceptor Bio has 23 total employees.
-
What industry is Inceptor Bio in?
Inceptor Bio’s primary industry is Biotechnology.
-
Is Inceptor Bio a private or public company?
Inceptor Bio is a Private company.
-
What is Inceptor Bio’s current revenue?
The current revenue for Inceptor Bio is .
-
How much funding has Inceptor Bio raised over time?
Inceptor Bio has raised $80.5M.
-
Who are Inceptor Bio’s investors?
Kineticos Life Sciences Management and Next Coast Ventures have invested in Inceptor Bio.
-
Who are Inceptor Bio’s competitors?
Poseida Therapeutics, Carisma Therapeutics, and Allogene Therapeutics are competitors of Inceptor Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process